Finsterer J. MELAS or Leigh syndrome, that’s the question. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(4):311-312. doi:10.5114/pedm.2022.112695.
APA
Finsterer, J. (2021). MELAS or Leigh syndrome, that’s the question. Pediatric Endocrinology Diabetes and Metabolism, 27(4), 311-312. https://doi.org/10.5114/pedm.2022.112695
Chicago
Finsterer, Josef. 2021. "MELAS or Leigh syndrome, that’s the question". Pediatric Endocrinology Diabetes and Metabolism 27 (4): 311-312. doi:10.5114/pedm.2022.112695.
Harvard
Finsterer, J. (2021). MELAS or Leigh syndrome, that’s the question. Pediatric Endocrinology Diabetes and Metabolism, 27(4), pp.311-312. https://doi.org/10.5114/pedm.2022.112695
MLA
Finsterer, Josef. "MELAS or Leigh syndrome, that’s the question." Pediatric Endocrinology Diabetes and Metabolism, vol. 27, no. 4, 2021, pp. 311-312. doi:10.5114/pedm.2022.112695.
Vancouver
Finsterer J. MELAS or Leigh syndrome, that’s the question. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(4):311-312. doi:10.5114/pedm.2022.112695.
With interest we read the article by Baszyńska-Wilk et al. about a 12 years old female who was diagnosed with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome upon the clinical presentation, blood tests, and the cerebral magnetic resonance imaging (MRI) [1]. The diagnosis was neither confirmed by biochemical nor by genetic investigations [1]. The study is appealing but raises the following concerns.
